Relay Therapeutics Inc
RLAY · NASDAQ
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
Market Data
Price
$12.91
-0.05 (-0.39%)
Market Cap$2.45B
P/E Ratio—
EPS$—
52W High$17.32
52W Low$2.67
Beta1.72
Data from Finnhub · Updated May 1, 2026